Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction

Journal of Neurochemistry

Volumn 117, Issue 1, 2011, Pages 100-111

  Rebola, Nelson ^a   Simões, Ana Patrícia ^a   Canas, Paula M ^a   Tomé, Angelo R ^a,b   Andrade, Geanne M ^a   Barry, Claire E ^c   Agostinho, Paula M ^a   Lynch, Marina A ^c   Cunha, Rodrigo A ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

A2A receptors; Adenosine; Long term potentiation; Microglia; Neuroinflammation

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; CASPASE 3; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; AUTACOID; RESORCINOL DERIVATIVE; SCH 725681;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN DYSFUNCTION; BRAIN ELECTROPHYSIOLOGY; CELL ACTIVATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENTATE GYRUS; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; IMMUNOREACTIVITY; LONG TERM POTENTIATION; MALE; MICROGLIA; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; SIGNAL TRANSDUCTION; TETANUS; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE CELL; NERVE CELL INHIBITION; PATHOLOGY; PHYSIOLOGY; SYNAPSE; WISTAR RAT;

RATTUS;

ANIMALS; HIPPOCAMPUS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; NEURAL INHIBITION; NEURONAL PLASTICITY; NEURONS; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RESORCINOLS; SYNAPSES;

EID: 79952548073     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07178.x     Document Type: Article

References (54)

1. Allan S. N., Tyrrell P. J. and Rothwell N. J. (2005) Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640.
2. Ballabh P., Braun A. and Nedergaard M. (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Brothers H. M., Marchalant Y. and Wenk G. L. (2010) Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci. Lett. 480, 97-100.
5. Canas P. M., Porciúncula L. O., Cunha G. M. A., Silva C. G., Machado N. J., Oliveira J. M. A., Oliveira C. R. and Cunha R. A. (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by β-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci. 29, 14741-14751.
6. Chakravarty S. and Herkenham M. (2005) Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 25, 1788-1796. (Pubitemid 40279284)
7. Chen J. F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M. A., Fink J. S. and Schwarzschild M. A. (1999) A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192-9200. (Pubitemid 30228071)
8. 2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. Prog. Neurobiol. 83, 310-331.
9. Chen G. Q., Chen Y. Y., Wang X. S., Wu S. Z., Yang H. M., Xu H. Q., He J. C., Wang X. T., Chen J. F. and Zheng R. Y. (2010) Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res. 1309, 116-125.
10. 2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. Eur. J. Pharmacol. 464, 33-38.
11. 2A receptors on long-term potentiation in the rat hippocampus upon aging. Soc. Neurosci. 541.18.
12. 2A receptor blockade. Purinergic Signal. 1, 111-134.
13. 2A receptors upon sub-chronic restraint stress. Neuroscience 141, 1775-1781.
14. 2A receptor regulation of neuroinflammation and traumatic brain injury. J. Neurosci. 30, 5802-5810.
15. 2A receptor blockade of β-amyloid neurotoxicity. Br. J. Pharmacol. 138, 1207-1209.
16. 2A receptor deficiency exacerbates white matter lesions and cognitive deficits induced by chronic cerebral hypoperfusion in mice. J. Neurol. Sci. 285, 39-45.
17. Duarte J. M., Nogueira C., Mackie K., Oliveira C. R., Cunha R. A. and Köfalvi A. (2007) Increase of cannabinoid CB1 receptor density in the hippocampus of streptozotocin-induced diabetic rats. Exp. Neurol. 204, 479-484.
18. Egeland M., Warner-Schmidt J., Greengard P. and Svenningsson P.. (2010) Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol. Psychiatry 67, 1048-1056.
19. Fredholm B. B., Chen J. F., Cunha R. A., Svenningsson P. and Vaugeois J. M. (2005) Adenosine and brain function. Int. Rev. Neurobiol. 63, 191-270.
20. Hauss-Wegrzyniak B., Lynch M. A., Vraniak P. D. and Wenk G. L. (2002) Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 176, 336-341.
21. Higashi H., Meno J. R., Marwaha A. S. and Winn H. R. (2002) Hippocampal injury and neurobehavioral deficits following hyperglycemic cerebral ischemia: effect of theophylline and ZM 241385. J. Neurosurg. 96, 117-126. (Pubitemid 34229996)
22. Jensen M. B., Finsen B. and Zimmer J. (1997) Morphological and immunophenotypic microglial changes in denervated fascia dentate of adult rats: correlation with blood brain barrier damage and astroglial reactions. Exp. Neurol. 143, 103-106.
23. Kelly A., Vereker E., Nolan Y., Brady M., Barry C., Loscher C. E., Mills K. H. and Lynch M. A. (2003) Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1beta on long-term potentiation in rat dentate gyrus. J. Biol. Chem. 278, 19453-19462.
24. Kim W. G., Mohney R. P.,Wilson B., Jeohn G. H., Liu B. and Hong J. S. (2000) Regional difference in susceptibility to lipopolysaccharideinduced neurotoxicity: role of microglia. J. Neurosci. 20, 6309-6316. (Pubitemid 30658427)
25. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
26. 2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br. J. Pharmacol. 128, 1035-1044.
27. 2A receptor knockout mice. Br. J. Pharmacol. 141, 1006-1014.
28. Marchetti B. and Abbracchio M. P. (2005) To be or not to be (inflamed) - is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol. Sci. 26, 517-525. (Pubitemid 41338562)
29. 2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann. Neurol. 49, 727-735.
30. 2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 1073-1074, 470-480.
31. 2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration. J. Neuropathol. Exp. Neurol. 66, 363-371.
32. 2a and Trk receptors. J. Neurosci. 26, 9250-9263.
33. 2a adenosine receptors. Glia 39, 133-147.
34. Nolan Y., Vereker E., Lynch A. M. and Lynch M. A. (2003) Evidence that lipopolysaccharide-induced cell death is mediated by accumulation of reactive oxygen species and activation of p38 in rat cortex and hippocampus. Exp. Neurol. 184, 794-804.
35. Ohnishi M., Katsuki H., Izumi Y., Kume T., Takada-Takatori Y. and Akaike A. (2010) Mitogen-activated protein kinases support survival of activated microglia that mediate thrombin-induced striatal injury in organotypic slice culture. J. Neurosci. Res. 88, 2155-2164.
36. Olesen J. and Leonardi M. (2003) The burden of brain diseases in Europe. Eur. J. Neurol. 10, 471-477.
37. 2A receptor mediates microglial process retraction. Nat. Neurosci. 12, 872-878.
38. Pierri M., Vaudano E., Sager T. and Englund U. (2005) KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse. Neuropharmacology 48, 517-524. (Pubitemid 40332409)
39. +-evoked glutamate release in the striatum. Eur. J. Pharmacol. 421, 177-180.
40. 2A receptor-mediated inhibition of TLR responses in microglia. J. Immunol. 182, 7603-7612.
41. 2A receptors prevents protein phosphorylation in the striatum induced by cortical stimulation. J. Neurosci. 26, 10808-10812.
42. 2A receptors in cortical neurotransmission to the striatal direct pathway. Sci.World J. 9, 1321-1344.
43. 2A receptors in the hippocampus and striatum of the rat. Neuroscience 132, 893-903.
44. 2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 57, 121-134.
45. Saura J., Angulo E., Ejarque A. et al. (2005) Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem. 95, 919-929. (Pubitemid 41713478)
46. Silva C. G., Porciúncula L. O., Canas P. M., Oliveira C. R. and Cunha R. A. (2007) Blockade of adenosine A2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons. Neurobiol. Dis. 27, 182-189.
47. 2 adenosine receptors? Trends Immunol. 26, 299-304.
48. 2A receptor antagonist. J. Neurosci. Res. 85, 1077-1085.
49. Trincavelli M. L., Melani A., Guidi S., Cuboni S., Cipriani S., Pedata F. and Martini C. (2008) Regulation of A2A adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J. Neurochem. 104, 479-490. (Pubitemid 350293874)
50. Vereker E., Campbell V., Roche E., McEntee E. and Lynch M. A. (2000) Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J. Biol. Chem. 275, 26252-26258.
51. Wirenfeldt M., Dissing-Olesen L., Anne Babcock A., Nielsen M., Meldgaard M., Zimmer J., Azcoitia I., Leslie R. G., Dagnaes-Hansen F. and Finsen B. (2007) Population control of resident and immigrant microglia by mitosis and apoptosis. Am. J. Pathol. 171, 617-631.
52. 2A receptor antagonists in Parkinson's disease. Pharmacol. Ther. 105, 267-310.
53. 2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat. Med. 10, 1081-1087.
54. 2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann. Neurol. 63, 338-346.